All Population Group | Allergen Test Subgroup | |||||||
---|---|---|---|---|---|---|---|---|
N (%) | OR (95% CI) | N (%) | OR (95% CI) | |||||
Crude Model | Adjusted Model I | Adjusted Model II | Crude Model | Adjusted Model I | Adjusted Model II | |||
Male | ||||||||
0 | 30 (2.7%) | Ref | Ref | Ref | 4 (1.4%) | Ref | Ref | Ref |
1 vs. 0 | 249 (22.3%) | 1.762 (1.132–2.744) * | 1.668 (1.046–2.662) * | 1.645 (1.029–2.630) * | 60 (20.5%) | 3.025 (1.074–8.519) * | 3.127 (1.068–9.157) * | 3.063 (1.034–9.073) * |
2 vs. 0 | 607 (54.3%) | 2.508 (1.633–3.853) *** | 1.959 (1.244–3.086) ** | 1.921 (1.217–3.033) ** | 169 (57.7%) | 4.903 (1.779–13.513) ** | 3.978 (1.389–11.386) * | 3.648 (1.261–10.559) * |
3 vs. 0 | 232 (20.8%) | 3.523 (2.243–5.536) *** | 2.464 (1.526–3.981) *** | 2.412 (1.489–3.906) *** | 60 (20.5%) | 6.382 (2.256–18.048) *** | 4.171 (1.412–12.317) * | 3.895 (1.304–11.634) * |
Female | ||||||||
0 | 22 (2.8%) | Ref | Ref | Ref | 1 (1.2%) | Ref | Ref | Ref |
1 vs. 0 | 170 (21.8%) | 1.283 (0.784–2.127) | 1.110 (0.661–1.863) | 1.041 (0.617–1.755) | 42 (25.1%) | 3.204 (0.756–13.572) | 2.555 (0.587–11.124) | 2.677 (0.599-11.954) |
2 vs. 0 | 437 (56.1%) | 1.652 (1.015–2.689) * | 1.178 (0.711–1.952) | 1.101 (0.662–1.833) | 91 (54.5%) | 3.385 (0.816–14.039) | 2.022 (0.470–8.695) | 2.013 (0.457–8.866) |
3 vs. 0 | 150 (19.3%) | 1.957 (1.173–3.267) * | 1.298 (0.761–2.214) | 1.217 (0.710–2.084) | 32 (19.2%) | 4.251 (0.995–18.158) | 2.272 (0.511–10.101) | 2.316 (0.507–10.568) |